Sarepta therapeutics, inc. revises earnings guidance for the full year of 2019

Sarepta therapeutics, inc. provided earnings guidance for the full year of 2019. 2019 revenue guidance range from $365 million to $375 million to a range of $370 million to $380 million for exondys 51.
SRPT Ratings Summary
SRPT Quant Ranking